4//SEC Filing
HAYDEN JEREMY B. 4
Accession 0001193125-26-018122
CIK 0001531177other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:53 PM ET
Size
6.5 KB
Accession
0001193125-26-018122
Research Summary
AI-generated summary of this filing
Sight Sciences (SGHT) Chief Legal Officer Jeremy Hayden Sells Shares
What Happened
- Jeremy B. Hayden, Chief Legal Officer of Sight Sciences (SGHT), sold 6,308 shares of common stock in an open-market transaction on January 16, 2026. The weighted-average price was $6.62 per share (range $6.44–$6.69), producing gross proceeds of approximately $41,759. The sale was made to cover the reporting person's tax liability in connection with the vesting of restricted stock units (RSUs).
Key Details
- Transaction date: 2026-01-16; Form 4 filed: 2026-01-21 (filed five days after the trade; Form 4s are generally due within two business days).
- Sale type/code: Open-market sale (S); reason per footnote: tax withholding related to RSU vesting (routine "sell-to-cover").
- Price details: Weighted avg $6.62; individual sale prices ranged $6.44 to $6.69; reporting person can provide exact breakdown on request.
- Reported ownership after transaction: 75,562 shares of common stock plus 192,049 shares that will be acquired upon vesting of RSUs (total reported interest = 267,611 shares, per footnote).
- Prior reporting notes: Footnotes clarify inclusion of previously omitted RSU shares and exclusion of certain option shares from the reported balance.
Context
- This was a sell-to-cover tied to RSU vesting (tax withholding), which is a routine administrative transaction and not necessarily an indicator of the insider’s view on the company’s prospects. The filing date is five days after the trade, which may indicate a late Form 4 filing relative to the typical two-business-day deadline.
Insider Transaction Report
Form 4
HAYDEN JEREMY B.
Chief Legal Officer
Transactions
- Sale
Common Stock
[F1][F2][F3][F4]2026-01-16$6.62/sh−6,308$41,759→ 267,611 total
Footnotes (4)
- [F1]Reflects shares of the Issuer's common stock, par value $0.001 per share ("common stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
- [F2]Reflects the weighted average price at which the shares of common stock were sold. The shares were sold in multiple transactions at prices ranging from $6.44 to $6.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes (i) 75,562 shares of common stock, and (ii) 192,049 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested.
- [F4]The Reporting Person previously reported a grant of 12,000 RSUs on a Form 4 filed on February 11, 2022 (which was subsequently included under Table 1 on a Form 4 filed on January 5, 2023) and a grant of 45,100 RSUs on a Form 4 filed on March 21, 2023, which were awarded on February 9, 2022 and March 16, 2023, respectively. Of these RSU grants, 39,825 shares were inadvertently excluded from the Reporting Person's beneficially owned shares. The reported balance includes these previously excluded shares. Furthermore, the Reporting Person's Form 4 filed on February 16, 2024 inadvertently included under Column 5 of Table I 11,326 shares of common stock underlying the Reporting Person's stock options that were to vest within 60 days of the date of such filing. The reported balance on this Form 4 excludes the number of shares underlying such stock options.
Signature
/s/Jeremy Hayden|2026-01-21
Documents
Issuer
Sight Sciences, Inc.
CIK 0001531177
Entity typeother
Related Parties
1- filerCIK 0001650737
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:53 PM ET
- Size
- 6.5 KB